BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lindstedt R, Ruggiero V, D' Alessio V, Manganello S, Petronzelli F, Stasi MA, Vendetti S, Assandri A, Carminati P, De Santis R. The immunosuppressor st1959, a 3,5-diaryl-s-triazole derivative, inhibits T cell activation by reducing NFAT nuclear residency. Int J Immunopathol Pharmacol 2009;22:29-42. [PMID: 19309550 DOI: 10.1177/039463200902200105] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
Number Citing Articles
1 Sieber M, Baumgrass R. Novel inhibitors of the calcineurin/NFATc hub - alternatives to CsA and FK506? Cell Commun Signal 2009;7:25. [PMID: 19860902 DOI: 10.1186/1478-811X-7-25] [Cited by in Crossref: 72] [Cited by in F6Publishing: 38] [Article Influence: 5.5] [Reference Citation Analysis]
2 Vegas AJ, Veiseh O, Doloff JC, Ma M, Tam HH, Bratlie K, Li J, Bader AR, Langan E, Olejnik K, Fenton P, Kang JW, Hollister-Locke J, Bochenek MA, Chiu A, Siebert S, Tang K, Jhunjhunwala S, Aresta-Dasilva S, Dholakia N, Thakrar R, Vietti T, Chen M, Cohen J, Siniakowicz K, Qi M, McGarrigle J, Graham AC, Lyle S, Harlan DM, Greiner DL, Oberholzer J, Weir GC, Langer R, Anderson DG. Combinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primates. Nat Biotechnol 2016;34:345-52. [PMID: 26807527 DOI: 10.1038/nbt.3462] [Cited by in Crossref: 259] [Cited by in F6Publishing: 222] [Article Influence: 43.2] [Reference Citation Analysis]
3 Kovacevic B, Jones M, Ionescu C, Walker D, Wagle S, Chester J, Foster T, Brown D, Mikov M, Mooranian A, Al-salami H. The emerging role of bile acids as critical components in nanotechnology and bioengineering: Pharmacology, formulation optimizers and hydrogel-biomaterial applications. Biomaterials 2022. [DOI: 10.1016/j.biomaterials.2022.121459] [Reference Citation Analysis]
4 Loiarro M, Campo S, Arseni B, Rossi S, D'alessio V, De Santis R, Sette C, Ruggiero V. Anti-proliferative effect of a triazole derivative (ST1959) on LNCaP human prostate cancer cells through down-regulation of cyclin and androgen receptor expression. Prostate 2011;71:32-41. [DOI: 10.1002/pros.21219] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
5 Qin JJ, Nag S, Wang W, Zhou J, Zhang WD, Wang H, Zhang R. NFAT as cancer target: mission possible? Biochim Biophys Acta 2014;1846:297-311. [PMID: 25072963 DOI: 10.1016/j.bbcan.2014.07.009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 50] [Article Influence: 3.6] [Reference Citation Analysis]
6 Kharb R, Sharma PC, Yar MS. Pharmacological significance of triazole scaffold. J Enzyme Inhib Med Chem 2011;26:1-21. [PMID: 20583859 DOI: 10.3109/14756360903524304] [Cited by in Crossref: 249] [Cited by in F6Publishing: 168] [Article Influence: 20.8] [Reference Citation Analysis]
7 Lee JU, Kim LK, Choi JM. Revisiting the Concept of Targeting NFAT to Control T Cell Immunity and Autoimmune Diseases. Front Immunol 2018;9:2747. [PMID: 30538703 DOI: 10.3389/fimmu.2018.02747] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 14.5] [Reference Citation Analysis]
8 Welch NG, Winkler DA, Thissen H. Antifibrotic strategies for medical devices. Adv Drug Deliv Rev 2020;167:109-20. [PMID: 32553685 DOI: 10.1016/j.addr.2020.06.008] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]